BF Investment Ltd
BFINVESTBF Investment Ltd is coiled. The quarters are improving, yet the P/BV sits at the 13th percentile of its own 10-year range — the business is moving before the market.
The sharpest disagreement: annual EPS moved +26.9% against a −3.7% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (9 weeks in) while the P/BV sits at the 13th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +284.2% year on year, with the the net margin at 1,327.3%. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
BF Investment Ltd trades at ₹448, in a confirmed uptrend and 9 weeks into that stage. That is +1.3% against its own 200-day average. It sits at 73% of a 52-week range of ₹342 to ₹487. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (1 week and counting).
Today the stock is in a confirmed uptrend — week 9 of stage 2, confirmed. At ₹448 it trades +1.3% versus its 200-day average and sits at 73% of its 52-week range (₹342–₹487).
Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +249% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (1 week and counting; last ahead the week of 2026-09-04) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Story check
BF Investment Ltd's story is not scored yet against the markers our research file set on 19 July 2026. Where it sits in its own cycle: Not stated in the research file. Still open: Promoter entities successfully delist the company at a price reflecting underlying asset value. Our fortnightly research layers last read it on 19 July 2026.
Our read, 19 July 2026. Deep-value holding company trading at a massive discount to book value, entirely dependent on Kalyani Group associate profits.
From the numbers. At trough multiple of book value.
From the price. Price stage 2, week 9 — above its 200-day line, relative strength falling.
From the research. Deep-value holding company trading at a massive discount to book value, entirely dependent on Kalyani Group associate profits.
🚨 Where they disagree. At trough multiple of book value.
What is proven. Deep-value holding company trading at a massive discount to book value, entirely dependent on Kalyani Group associate profits.
What is not proven yet. Promoter entities successfully delist the company at a price reflecting underlying asset value.
🚨 What would change our mind. Promoter entities successfully delist the company at a price reflecting underlying asset value.
🚨 Layer 1 read, 19 July 2026 — DROP. Cheapest name in the batch on paper, but a Kalyani holdco discount that only unlocks on a delisting that was already rejected. P/BV 0.21 is a 78% discount to book yet the 'earnings' are lumpy associate marks that swung 250 -> -3 -> 114 Cr across recent quarters with the latest quarter flagged as a 2.9x spike — not operating leverage. With no moat and the value-unlock delisting already rejected, the discount is structural, so I rank it to the bottom of KEEP rather than reward the cheapness.
What would change Layer 1’s mind. Promoter entities successfully delisting (or demerging) the company at a price reflecting underlying asset value (its own falsification, sharpened) — that would convert the book discount into realized value and lift this off the bottom; short of a concrete unlock, the discount stays a trap.
The test written in advance. Promoter entities successfully delist the company at a price reflecting underlying asset value. — the thesis as written as stated by the next result.
What the company does. BFINVEST is a pure-play investment vehicle for the Kalyani Group. Its standalone operations are minimal, and its value is derived from its holdings in associate companies. A recent failed delisting attempt highlights the trapped value, but structural catalysts like demergers or regulatory changes could unlock it.
🚨 What the surface reading misses. The surface reading is: The stock appears extremely cheap on a price-to-book basis. The research reads it further: This is a typical holding company discount that may persist perpetually without a catalyst.
Sources: our stock research file (19 July 2026) · quarterly results through Jun 26. The story check is re-scored every results season; the record below never changes.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
BF Investment Ltd reported ₹11.0 Cr of income in the Jun 26 quarter, +22.2% year on year. That is the 3rd straight quarter of year-on-year growth. Over 10 years it has compounded at −22.6% a year. The last full year, FY26, came in at ₹76.0 Cr. The last four reported quarters add to ₹77.0 Cr.
FY26 revenue came in at ₹76.0 Cr (+20.6% on the year), capping 10 years at −22.6% compound. The latest quarter (Jun 26) printed ₹11.0 Cr, +22.2% year on year — the 3rd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +18.9% growth against the decade's −22.6% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +22.2% over the last 4 quarters against +30.8%/yr over the last 8 — rolling over; TTM profit +398.7% vs −16.7%/yr — accelerating.
FY26-Q4. revenue ₹37 Cr and profit ₹114 Cr as reported.
FY27-Q1. revenue ₹11 Cr and profit ₹146 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
BF Investment Ltd's net margin is 1,327.3% in the Jun 26 quarter, +905.1 percentage points against the same quarter a year ago. Across 11 fiscal years the net margin has ranged 12.6% to 1,668.8%. The current quarter sits inside that band.
The latest quarter's net margin is 1,327.3%, +905.1 pp against the same quarter a year ago. Across 11 fiscal years the net margin has ranged 12.6%–1,668.8%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
FY26-Q4. revenue ₹37 Cr and profit ₹114 Cr as reported.
FY27-Q1. revenue ₹11 Cr and profit ₹146 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
BF Investment Ltd earned ₹146 Cr of net profit in the Jun 26 quarter, +284.2% year on year. Full-year FY26 profit was ₹282 Cr. The 10-year compound rate is 7.9%. That is 1,327.3% of the quarter's revenue. The same quarter a year earlier earned ₹38.0 Cr. 1 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹146 Cr, +284.2% year on year. On the full year, FY26 printed ₹282 Cr (+27.0%), and the 10-year compound rate is 7.9%.
Why profit moved: revenue contributed +22.2% and the margin +905.1 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +488.9% vs revenue +18.9%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
FY26-Q4. revenue ₹37 Cr and profit ₹114 Cr as reported.
FY27-Q1. revenue ₹11 Cr and profit ₹146 Cr as reported.
Why-sources: our stock research file (19 July 2026) and the company’s own results for those quarters.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for BF Investment Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
BF Investment Ltd's revenue grew +20.6% in FY26 to ₹76.0 Cr, so the book is growing. The latest quarter ran +22.2% year on year. The net margin on that income is 1,327.3%, +905.1 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY26 revenue was ₹76.0 Cr, +20.6% on the year, and the latest quarter ran +22.2% year on year. The net margin on that revenue is 1,327.3% this quarter (+905.1 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers usually rate a lender: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys.
A clean annual return-on-equity ladder is not held for BF Investment Ltd. For an insurer especially the standard bank ratios are not the right lens, so this page does not force them onto the filings rather than estimating a series it cannot support. The revenue, margin and ownership sections above and below are the reads this page stands behind.
We do not hold a clean annual return-on-equity series for BF Investment Ltd — for an insurer especially, the standard bank ratios are not the right lens, so this page does not force them. The revenue, margin and ownership sections above and below are the reads we stand behind.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 1.0 points of BF Investment Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 0.7% of the company. Domestic institutions moved +0.1 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
Why this happened. Any successful attempt to delist or spin off assets will directly narrow the holding discount.
The register over the last two years — Foreign institutions: −1.0 points over 8 quarters to 0.7%; Domestic institutions: +0.1 points over 8 quarters to 0.1%; Promoters: +0.0 points over 8 quarters to 74.1%.
🚨 Why the register moved: foreign institutions drove it (−1.0 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
BF Investment Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
BF Investment Ltd trades at 0.2× P/BV, near the bottom of its own range — cheaper only 13% of the time. Its long-run median P/BV is 0.4×, measured across 9.9 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 0.2× is near the bottom of its own range — cheaper only 13% of the time, against a long-run median of 0.4× measured over 9.9 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 4% on its equity is worth less per rupee of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
Why the multiple sits where it does: over the past year book value grew while the price moved −3.7% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +4.2%/yr price move, ~+19.7%/yr came from book-value growth and ~−15.5 pp from the multiple (compressing); over 10y, of the +10.4%/yr price move, ~+23.0%/yr came from book-value growth and ~−12.6 pp from the multiple (compressing). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is low against its own past, so the story rests on the book-value line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
What the price assumes This reading works the multiple backwards. It asks one question: what yearly rate of profit growth is a buyer at the market price already paying for? The number is the growth rate that makes eleven years of profit — six years growing, then five fading — add up to that day's market price, once each year is discounted at 11% a year.
Solved at its 20 July 2026 price, BF Investment Ltd was paying for profit growth of about −1.4% a year. Profit itself has compounded 7.9% a year over the past 10 years. Today the market pays 0.2× P/BV, the 13th percentile of its own 10-year range.
What the two numbers say together. The multiple is low against its own past, and the growth the price is paying for is below what this company has actually delivered.
How to hold this number: it is a reading of one day's price, taken on 20 July 2026, not a running figure — every other number on this page, the multiple included, is read off the live quote as of 11 September 2026. A higher price is paying for more growth and a lower price for less, so it moves whenever the price does, and this page does not restate it between measurements.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
BF Investment Ltd reads as turning around on its fundamental arc. Turning around — EPS growth swung from −84.4% at the trough to +398.5%, a 3-quarter improving streak. The read is built from 8 quarters across 3 curves, on partial evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +20.6% | +34.8% | +36.6% | −22.6% |
| Profit | +27.0% | +2.9% | +1.1% | +7.9% |
| EPS | +26.9% | +2.8% | +1.1% | +7.9% |
| Share price | −3.7% | −6.5% | +4.2% | +10.4% |
4-Factor Sector Score
60.1/100 — rank 5 of 34 in Finance & Investments - Others · 86% evidence confidence
BF Investment Ltd scores 60.1 out of 100 against the 34 companies it is compared with in Finance & Investments - Others, ranking 5. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 27.3 + 12.1 + 8 + 12.7 = 60.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Fedders Holding LtdFEDDERSHOL | 74.7/100Favorable setup80% evidence | BREAKING OUT | 25.1/35 Income -6.4% · PAT 100% 81% evidence | 18.3/25 ROA 10.9% · ROE 11.6% · GNPA — 68% evidence | 12.8/20 P/BV 1.35× · P/BV÷ROE 0.12 70% evidence | 18.5/20 RS sector 7.4% · RS bench 9.2% · 1Y 5.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 25.1 + 18.3 + 12.8 + 18.5 = 74.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Abans Financial Services LtdAFSL | 70.5/100Favorable setup80% evidence | TURNING | 24.3/35 Income 100% · PAT 17.9% 81% evidence | 14.5/25 ROA 3.6% · ROE 8.3% · GNPA — 68% evidence | 17.0/20 P/BV 0.81× · P/BV÷ROE 0.1 100% evidence | 14.7/20 RS sector 21% · RS bench 0.4% · 1Y -8.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 24.3 + 14.5 + 17 + 14.7 = 70.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Gretex Corporate Services LtdGCSL | 63.8/100Mixed-positive evidence86% evidence | LEADER | 24.5/35 Income -19.4% · PAT 100% 81% evidence | 18.5/25 ROA 11.5% · ROE 12.7% · GNPA — 68% evidence | 1.6/20 P/BV 8.3× · P/BV÷ROE 0.65 100% evidence | 19.2/20 RS sector 56.1% · RS bench 60.7% · 1Y 97.3%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 18.5 + 1.6 + 19.2 = 63.8 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 4Saraswati Commercial (India) LtdZSARACOM | 63.2/100Mixed-positive evidence80% evidence | BREAKING OUT | 30.6/35 Income 100% · PAT 100% 81% evidence | 15.2/25 ROA 7.6% · ROE 8.9% · GNPA — 68% evidence | 11.6/20 P/BV 1.07× · P/BV÷ROE 0.12 100% evidence | 5.8/20 RS sector -17% · RS bench -3.6% · 1Y -16.2%8 of 8 weeks ahead 70% evidence |
| Exact sum: 30.6 + 15.2 + 11.6 + 5.8 = 63.2 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -17% and the one-year return is -16.2%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 5BF Investment Ltdthis pageBFINVEST | 60.1/100Mixed-positive evidence86% evidence | FADING | 27.3/35 Income 22.2% · PAT 100% 81% evidence | 12.1/25 ROA 3% · ROE 3.6% · GNPA — 68% evidence | 8.0/20 P/BV 0.2× · P/BV÷ROE 0.06 100% evidence | 12.7/20 RS sector 3.2% · RS bench 5.5% · 1Y -2.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 27.3 + 12.1 + 8 + 12.7 = 60.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Algoquant Fintech LtdALGOQUANT | 60.0/100Mixed-positive evidence74% evidence | BREAKING OUT | 20.0/35 Income 15.7% · PAT 100% 81% evidence | 20.3/25 ROA 12% · ROE 28.4% · GNPA — 68% evidence | 4.6/20 P/BV 13.51× · P/BV÷ROE 0.48 70% evidence | 15.1/20 RS sector 4.5% · RS bench 6.8% · 1Y -7.5%8 of 10 weeks ahead 70% evidence |
| Exact sum: 20 + 20.3 + 4.6 + 15.1 = 60 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 7CSL Finance LtdCSLFINANCE | 59.4/100Mixed-positive evidence90% evidence | BASING | 20.8/35 Income 19.7% · PAT 14.7% 76% evidence | 22.4/25 ROA 9% · ROE 14.9% · GNPA 0.9% 95% evidence | 12.0/20 P/BV 0.81× · P/BV÷ROE 0.05 100% evidence | 4.2/20 RS sector -14.3% · RS bench -12.5% · 1Y -25.1%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 22.4 + 12 + 4.2 = 59.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Master Trust LtdMASTERTR | 56.5/100Mixed-positive evidence80% evidence | TURNING | 13.3/35 Income 7% · PAT 8.1% 81% evidence | 18.9/25 ROA 5.6% · ROE 17.3% · GNPA — 68% evidence | 15.0/20 P/BV 1.36× · P/BV÷ROE 0.08 70% evidence | 9.3/20 RS sector -7% · RS bench -5.7% · 1Y -42%6 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 18.9 + 15 + 9.3 = 56.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 9STEL Holdings LtdSTEL | 54.1/100Mixed-positive evidence80% evidence | BREAKING OUT | 25.9/35 Income 20.7% · PAT 21.6% 81% evidence | 9.0/25 ROA 1.2% · ROE 1.2% · GNPA — 68% evidence | 2.9/20 P/BV 0.7× · P/BV÷ROE 0.59 100% evidence | 16.3/20 RS sector 20.5% · RS bench 24.4% · 1Y 30.3%10 of 10 weeks ahead 70% evidence |
| Exact sum: 25.9 + 9 + 2.9 + 16.3 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Mufin Green Finance LtdMUFIN | 52.6/100Mixed-positive evidence82% evidence | LEADER | 24.0/35 Income 27.8% · PAT 100% 86% evidence | 11.2/25 ROA 1.3% · ROE 6.7% · GNPA — 72% evidence | 3.9/20 P/BV 4.66× · P/BV÷ROE 0.7 70% evidence | 13.5/20 RS sector 14.4% · RS bench 17.5% · 1Y 60.5%11 of 12 weeks ahead 100% evidence |
| Exact sum: 24 + 11.2 + 3.9 + 13.5 = 52.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Dolat Algotech LtdDOLATALGO | 52.5/100Mixed-positive evidence80% evidence | BASING | 8.5/35 Income -11.6% · PAT -21.2% 81% evidence | 18.1/25 ROA 8.5% · ROE 12.1% · GNPA — 68% evidence | 17.1/20 P/BV 1.08× · P/BV÷ROE 0.09 100% evidence | 8.8/20 RS sector -0.8% · RS bench -8.7% · 1Y -15.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 8.5 + 18.1 + 17.1 + 8.8 = 52.5 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 12Balmer Lawrie Investment LtdBLIL | 51.4/100Mixed-positive evidence86% evidence | BASING | 14.8/35 Income 8.8% · PAT 4.1% 81% evidence | 18.3/25 ROA 7.9% · ROE 12.7% · GNPA — 68% evidence | 13.9/20 P/BV 1.06× · P/BV÷ROE 0.08 100% evidence | 4.4/20 RS sector -7.3% · RS bench -5.1% · 1Y -26.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 18.3 + 13.9 + 4.4 = 51.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 13Bengal & Assam Company LtdBENGALASM | 51.3/100Mixed-positive evidence64% evidence | 16.7/35 Income 12.1% · PAT 3.4% 62% evidence | 12.8/25 ROA — · ROE 8.1% · GNPA — 34% evidence | 15.9/20 P/BV 0.67× · P/BV÷ROE 0.08 100% evidence | 5.9/20 RS sector -9.4% · RS bench -6.2% · 1Y -26%1 of 8 weeks ahead 70% evidence | |
| Exact sum: 16.7 + 12.8 + 15.9 + 5.9 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14PTC India Financial Services LtdPFS | 50.8/100Mixed-positive evidence80% evidence | BASING | 12.4/35 Income -22.7% · PAT -27.8% 81% evidence | 16.8/25 ROA 6.5% · ROE 11% · GNPA — 68% evidence | 15.8/20 P/BV 0.57× · P/BV÷ROE 0.05 100% evidence | 5.8/20 RS sector -7.1% · RS bench -12% · 1Y -27.9%1 of 10 weeks ahead 70% evidence |
| Exact sum: 12.4 + 16.8 + 15.8 + 5.8 = 50.8 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 15Consolidated Finvest & Holdings LtdCONSOFINVT | 48.1/100Mixed-negative evidence86% evidence | BREAKING OUT | 8.1/35 Income -9.1% · PAT -43.9% 81% evidence | 13.7/25 ROA 4.3% · ROE 5% · GNPA — 68% evidence | 7.1/20 P/BV 0.84× · P/BV÷ROE 0.17 100% evidence | 19.2/20 RS sector 36.6% · RS bench 40.7% · 1Y 54.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 8.1 + 13.7 + 7.1 + 19.2 = 48.1 · Decision use: Price leads the evidence: RS versus the benchmark is 40.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 16Industrial & Prudential Investment Company LtdINDPRUD | 45.6/100Mixed-negative evidence80% evidence | ASLEEP | 12.5/35 Income -40% · PAT -3.2% 81% evidence | 15.6/25 ROA 7.3% · ROE 7.7% · GNPA — 68% evidence | 6.3/20 P/BV 1.23× · P/BV÷ROE 0.16 100% evidence | 11.2/20 RS sector -3.5% · RS bench 6% · 1Y -1.7%0 of 9 weeks ahead 70% evidence |
| Exact sum: 12.5 + 15.6 + 6.3 + 11.2 = 45.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Finkurve Financial Services LtdFINKURVE | 45.3/100Mixed-negative evidence74% evidence | BREAKING OUT | 21.0/35 Income 59.6% · PAT 62.2% 81% evidence | 14.1/25 ROA 2.1% · ROE 9.4% · GNPA — 68% evidence | 6.0/20 P/BV 2.95× · P/BV÷ROE 0.31 70% evidence | 4.2/20 RS sector -34.3% · RS bench -8.4% · 1Y -29.3%5 of 11 weeks ahead 70% evidence |
| Exact sum: 21 + 14.1 + 6 + 4.2 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18VLS Finance LtdVLSFINANCE | 44.4/100Mixed-negative evidence80% evidence | BREAKING OUT | 18.1/35 Income -8.4% · PAT 91.7% 81% evidence | 7.5/25 ROA 1% · ROE 0.9% · GNPA — 68% evidence | 4.9/20 P/BV 0.36× · P/BV÷ROE 0.38 100% evidence | 13.9/20 RS sector 9.4% · RS bench -1% · 1Y 9.4%4 of 10 weeks ahead 70% evidence |
| Exact sum: 18.1 + 7.5 + 4.9 + 13.9 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19PTL Enterprises LtdPTL | 44.4/100Mixed-negative evidence75% evidence | ASLEEP | 16.4/35 Income 0% · PAT 13.5% 52% evidence | 13.8/25 ROA 3.3% · ROE 5.5% · GNPA — 68% evidence | 8.0/20 P/BV 0.6× · P/BV÷ROE 0.11 100% evidence | 6.2/20 RS sector -3.9% · RS bench -1.5% · 1Y -3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 13.8 + 8 + 6.2 = 44.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20PNB Gilts LtdPNBGILTS | 41.4/100Mixed-negative evidence80% evidence | ASLEEP | 9.1/35 Income -5.3% · PAT -69.7% 81% evidence | 9.9/25 ROA 0.7% · ROE 11.1% · GNPA — 68% evidence | 15.3/20 P/BV 0.85× · P/BV÷ROE 0.08 100% evidence | 7.1/20 RS sector -13.5% · RS bench -1.1% · 1Y -17.8%5 of 10 weeks ahead 70% evidence |
| Exact sum: 9.1 + 9.9 + 15.3 + 7.1 = 41.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 21NBI Industrial Finance Company LtdNBIFIN | 41.1/100Mixed-negative evidence69% evidence | TURNING | 20.8/35 Income 55.5% · PAT 65.2% 33% evidence | 6.1/25 ROA 0.3% · ROE 0.4% · GNPA — 68% evidence | 4.6/20 P/BV 0.23× · P/BV÷ROE 0.55 100% evidence | 9.6/20 RS sector -5.3% · RS bench -3.4% · 1Y -20%4 of 12 weeks ahead 100% evidence |
| Exact sum: 20.8 + 6.1 + 4.6 + 9.6 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Authum Investment & Infrastructure LtdAIIL | 40.9/100Mixed-negative evidence70% evidence | FADING | 8.6/35 Income -34.6% · PAT -48.8% 62% evidence | 15.2/25 ROA — · ROE 12.8% · GNPA — 34% evidence | 5.5/20 P/BV 3.14× · P/BV÷ROE 0.24 100% evidence | 11.6/20 RS sector 1.4% · RS bench 3.6% · 1Y -11.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 8.6 + 15.2 + 5.5 + 11.6 = 40.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Capital India Finance LtdCIFL | 39.7/100Thin evidence · provisional57% evidence | BASING | 17.7/35 Income -1.5% · PAT 100% 52% evidence | 8.8/25 ROA 1.7% · ROE -8.6% · GNPA — 68% evidence | 9.2/20 P/BV 1.17× · P/BV÷ROE — 40% evidence | 4.0/20 RS sector -17.3% · RS bench -28.9% · 1Y -39.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.7 + 8.8 + 9.2 + 4 = 39.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24Grand Oak Canyons Distillery LtdGRANDOAK | 38.9/100Mixed-negative evidence71% evidence | BREAKING OUT | 23.4/35 Income 100% · PAT 100% 54% evidence | 4.0/25 ROA 0.1% · ROE 0% · GNPA — 72% evidence | 0.7/20 P/BV 2.15× · P/BV÷ROE 215 100% evidence | 10.8/20 RS sector 2% · RS bench -5% · 1Y -13.4%9 of 9 weeks ahead 70% evidence |
| Exact sum: 23.4 + 4 + 0.7 + 10.8 = 38.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25The Investment Trust of India LtdTHEINVEST | 37.9/100Mixed-negative evidence75% evidence | TURNING | 11.7/35 Income -22.4% · PAT -13.9% 52% evidence | 11.9/25 ROA 2.7% · ROE 4% · GNPA — 68% evidence | 8.0/20 P/BV 0.69× · P/BV÷ROE 0.17 100% evidence | 6.3/20 RS sector -12.6% · RS bench -10.9% · 1Y -36.9%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.7 + 11.9 + 8 + 6.3 = 37.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Nalwa Sons Investments LtdNSIL | 36.2/100Mixed-negative evidence76% evidence | TURNING | 18.8/35 Income -20.3% · PAT 37.2% 86% evidence | 5.9/25 ROA 0.3% · ROE 0.3% · GNPA — 72% evidence | 5.0/20 P/BV 0.19× · P/BV÷ROE 0.56 70% evidence | 6.5/20 RS sector -6.7% · RS bench -7.8% · 1Y -21.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.8 + 5.9 + 5 + 6.5 = 36.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Prime Securities LtdPRIMESECU | 34.2/100Adverse evidence86% evidence | ASLEEP | 8.9/35 Income 14.4% · PAT -80% 81% evidence | 13.4/25 ROA 4.6% · ROE 4.1% · GNPA — 68% evidence | 3.2/20 P/BV 3.74× · P/BV÷ROE 0.91 100% evidence | 8.7/20 RS sector -1.6% · RS bench 0.9% · 1Y 7.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.9 + 13.4 + 3.2 + 8.7 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28Crest Ventures LtdCREST | 33.0/100Adverse evidence86% evidence | ASLEEP | 7.1/35 Income -33.2% · PAT -49.3% 81% evidence | 12.4/25 ROA 2.5% · ROE 3.8% · GNPA — 68% evidence | 8.0/20 P/BV 0.77× · P/BV÷ROE 0.2 100% evidence | 5.5/20 RS sector -4.1% · RS bench -1.8% · 1Y -5.7%2 of 12 weeks ahead 100% evidence |
| Exact sum: 7.1 + 12.4 + 8 + 5.5 = 33 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Kiran Vyapar LtdKIRANVYPAR | 32.6/100Adverse evidence64% evidence | BREAKING OUT | 10.2/35 Income 0.9% · PAT -80% 62% evidence | 7.3/25 ROA 1.1% · ROE 0.1% · GNPA — 68% evidence | 3.4/20 P/BV 0.25× · P/BV÷ROE 5 100% evidence | 11.7/20 RS sector — · RS bench 5.2% · 1Y —4 of 7 weeks ahead 25% evidence |
| Exact sum: 10.2 + 7.3 + 3.4 + 11.7 = 32.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 30Dhunseri Investments LtdDHUNINV | 30.8/100Adverse evidence73% evidence | BREAKING OUT | 15.5/35 Income -12.3% · PAT 17.1% 62% evidence | 5.0/25 ROA -0.5% · ROE 0.7% · GNPA — 68% evidence | 5.3/20 P/BV 0.22× · P/BV÷ROE 0.33 100% evidence | 5.0/20 RS sector -34.7% · RS bench -3.5% · 1Y -29.7%6 of 6 weeks ahead 70% evidence |
| Exact sum: 15.5 + 5 + 5.3 + 5 = 30.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 31Systematix Corporate Services LtdSYSTMTXC | 29.3/100Adverse evidence74% evidence | TURNING | 9.4/35 Income 14.4% · PAT -80% 81% evidence | 12.4/25 ROA 3.2% · ROE 4.6% · GNPA — 68% evidence | 4.1/20 P/BV 3.15× · P/BV÷ROE 0.68 70% evidence | 3.4/20 RS sector -38.5% · RS bench -20.7% · 1Y -40.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 9.4 + 12.4 + 4.1 + 3.4 = 29.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 32Oswal Green Tech LtdOSWALGREEN | 27.9/100Adverse evidence75% evidence | BASING | 8.8/35 Income -46.8% · PAT -80% 52% evidence | 8.2/25 ROA 1.1% · ROE 1.5% · GNPA — 68% evidence | 8.0/20 P/BV 0.22× · P/BV÷ROE 0.15 100% evidence | 2.9/20 RS sector -29.4% · RS bench -28.2% · 1Y -50.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 8.8 + 8.2 + 8 + 2.9 = 27.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 33Spice Lounge Food Works LtdSPICELOUNG | 44.4/100Thin evidence · provisional44% evidence | 20.2/35 Income 20.9% · PAT 100% 22% evidence | 12.0/25 ROA — · ROE 8.4% · GNPA — 34% evidence | 3.3/20 P/BV 15.85× · P/BV÷ROE 1.9 70% evidence | 8.9/20 RS sector 0.7% · RS bench -20.9% · 1Y -43%2 of 12 weeks ahead 70% evidence | |
| Exact sum: 20.2 + 12 + 3.3 + 8.9 = 44.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Eraaya Lifespaces LtdEBIX | 39.5/100Thin evidence · provisional22% evidence | 17.5/35 Income — · PAT — 0% evidence | 9.3/25 ROA — · ROE -809% · GNPA — 26% evidence | 9.2/20 P/BV 6.36× · P/BV÷ROE — 10% evidence | 3.5/20 RS sector -34.1% · RS bench -39.5% · 1Y -45.3%8 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 17.5 + 9.3 + 9.2 + 3.5 = 39.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is BF Investment Ltd's share price today?
BF Investment Ltd trades at ₹448, −3.7% over the past year. The company is valued at ₹1,688 Cr. The stock sits at 73% of its 52-week range of ₹342–₹487, +1.3% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 9 weeks in. — as of 11 September 2026.
What were BF Investment Ltd's latest quarterly results?
BF Investment Ltd reported total income of ₹11.0 Cr and net profit of ₹146 Cr for the Jun 26 quarter. Income rose 22.2% and profit rose 284.2% year on year. Earnings per share were ₹38.76. The net margin was 1,327.3%, 905.1 pp higher than a year earlier. — as of 11 September 2026.
What is BF Investment Ltd's revenue?
BF Investment Ltd reported revenue of ₹11.0 Cr in the Jun 26 quarter, +22.2% year on year. For the full FY26 fiscal year, revenue was ₹76.0 Cr (+20.6%). Over the last 10 years revenue compounded at −22.6% a year. — as of 11 September 2026.
What is BF Investment Ltd's profit?
BF Investment Ltd earned ₹146 Cr of net profit in the Jun 26 quarter, +284.2% year on year. Full-year FY26 profit was ₹282 Cr. The net margin ran 1,327.3% in the latest quarter. — as of 11 September 2026.
What is BF Investment Ltd's market cap?
BF Investment Ltd's market capitalisation is ₹1,688 Cr at a share price of ₹448. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
What is BF Investment Ltd's P/BV ratio?
BF Investment Ltd trades at a P/BV of 0.2×, at the 13th percentile of its own 10-year range, against a long-run median of 0.4×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.
Does BF Investment Ltd pay a dividend?
No — BF Investment Ltd has recorded a dividend payout of 0% of profit in each of its last 11 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
Is BF Investment Ltd overvalued?
On its own history, BF Investment Ltd looks cheap: its P/BV of 0.2× has been cheaper only 13% of the time in 10 years (long-run median 0.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.
Is BF Investment Ltd growing?
Yes — BF Investment Ltd is growing: latest-quarter revenue +22.2% year on year, profit +284.2%, and the net margin +905.1 pp at 1,327.3%. The 10-year compound rates are −22.6% (revenue) and 7.9% (profit). The earnings engine currently reads: improving — as of 11 September 2026.
How is BF Investment Ltd performing?
BF Investment Ltd is in a confirmed uptrend, 9 weeks in. Its latest quarter's income rose 22.2% and profit rose 284.2% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 1 week. This describes what the data did, not a rating. — as of 11 September 2026.
What stage is BF Investment Ltd in?
Turning around — EPS growth swung from −84.4% at the trough to +398.5%, a 3-quarter improving streak. The read comes from the last 12 quarters of growth (revenue growth +22.2% latest, profit growth +398.7% latest, eps growth +398.5% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.
Is BF Investment Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 9 of stage 2), trading +1.3% versus its 200-day average and at 73% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is BF Investment Ltd beating the market?
Not lately — on a trailing-13-week view BF Investment Ltd is currently behind the NIFTY 500 (1 week and counting; last ahead the week of 2026-09-04), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +249% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.
Will BF Investment Ltd's share price go up?
This page publishes no price forecast for BF Investment Ltd. What it measures instead: the share price is ₹448, the price is in a confirmed uptrend 9 weeks in. Its P/BV of 0.2× sits at the 13th percentile of its own 10-year range. — as of 11 September 2026.
Who owns BF Investment Ltd?
Promoters hold 74.1% of BF Investment Ltd, foreign institutions 0.7%, domestic institutions 0.1% and the public 25.0% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 1.0 points over 8 quarters. — as of 11 September 2026.
Where is BF Investment Ltd in its business cycle?
BF Investment Ltd's FY26 net margin was 371.1%, against a 11-year band of 12.6%–1,668.8%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 1,327.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What growth does BF Investment Ltd's price assume?
At its price on 20 July 2026, BF Investment Ltd was priced for profit growth of about −1.4% a year. Profit itself has compounded 7.9% a year over the past 10 years. The figure reads the multiple backwards: the growth a buyer at that price was already paying for. — as of 11 September 2026.
What could break the BF Investment Ltd story?
The sharpest disagreement: annual EPS moved +26.9% against a −3.7% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is BF Investment Ltd a stock worth studying right now?
This is not investment advice. The machine read: BF Investment Ltd is coiled. The quarters are improving, yet the P/BV sits at the 13th percentile of its own 10-year range — the business is moving before the market. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!